Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
10xBio
La Jolla, California, United States10xbio.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
10XB101 demonstrated superior efficacy and tolerability compared to deoxycholate in Phase 2b trials for submental body contouring, showing enhanced patient tolerability, fewer side effects, and shorter treatment intervals
- Therapeutic areas
- EndocrinologyDermatology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Hugel
Beyond the preview
Go deeper on 10xBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 10xBio.